BYs
s8m
IJc
qQf
NzU
Bhw
IMn
AzC
1OL
lrT
hzO
th3
bLE
HgE
aVi
N8Z
es0
Llm
vBD
j7I
招生信息
教师照片
教师博客
首页
科学研究
研究领域
论文成果
专利
著作成果
科研项目
科研团队
教学研究
教学资源
授课信息
教学成果
获奖信息
招生信息
学生信息
我的相册
教师博客
其他栏目
语种
English
展鹏
教授 博士生导师 硕士生导师
性别：男
毕业院校：山东大学
学历：博士研究生毕业
学位：医学博士学位
在职信息：在职
所在单位：药学院
入职时间： 2010-07-26
所属院系： 齐鲁医学院 , 药学院 , 药学院 , 药学院 , 药学院
办公地点：山东大学国家大学生科技园（二环南路）3号楼14层1435房间
电子邮箱：
43475ab55117606bcace1677d6523de94606e6ab2e7d6d3a63892f74b49c1dfebc61b109aa32dcf2a2f92ff506fa370d9aa2a5a2fa85e93335003c553876fed5910feaf27b75060b4bfebdb2b5a315b925629d4c5a3385acc673ed347e0077816aecbaa4f1622a488fa0f0199622069d129ec4f5c8ef4f1ae3ef9a5683838ef4
访问量：
开通时间：
.
.
最后更新时间：
.
.
论文成果
当前位置
中文主页
>>
科学研究
>>
论文成果
[61] 展鹏 , 刘新泳 and 刘新泳. Recent Advances in the Structure-based Rational Design of TNKSIs.. Mol. BioSyst.,, 2014.
[62] 展鹏 , 刘新泳 and 刘新泳. Discovery of novel indolylarylsulfones as potent HIV-1 NNRTIs via structure-guided scaffold morphing. EUR J MED CHEM, 2019.
[63] 展鹏 , 刘新泳 , 刘新泳 and 260101160045. Overview of Recent Strategic Advances in Medicinal Chemistry. J Med Chem, 2019.
[64] 梁晓红 , 刘新泳 , 展鹏 and 刘新泳. Design, Synthesis and Evaluation of Novel Heteroaryldihydropyrimidines Derivatives as Non-nucleoside Hepatitis B Virus Inhibitors by Exploring the Solvent-exposed Region. Chem Biol Drug Des, 2019.
[65] 展鹏 , 刘新泳 and 贾海永. Design, synthesis and primary biological evaluation of the novel 2-pyridone derivatives as potent non-nucleoside HBV inhibitors. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 136, 144, 2017.
[66] 刘新泳 , 展鹏 , 张硕 and 260101160045. Efficient drug discovery by rational lead hybridization based on crystallographic overlay. Drug Discovery Today, 24, 805, 2019.
[67] 黄伯世 , 展鹏 and 刘新泳. Discovery of novel DAPY-IAS hybrid derivatives as potential HIV-1 inhibitors using molecular hybridization based on crystallographic overlays. Bioorganic & medicinal chemistry, 25, 4397, 2017.
[68] 展鹏 , 刘新泳 and 孟青. The development of an effective synthetic route of lesinurad (RDEA594). Chemistry Central Journal, 11, 2017.
[69] 展鹏 , 刘新泳 and 刘新泳. HIV-1非核苷类逆转录酶抑制剂的研究进展（2014-2015）. 《中国科技论文在线》, 2015.
[70] 刘新泳 , 展鹏 and 刘新泳. CDC25 磷酸酶抑制剂研究进展( 2008 ～ 2014 年). 《中国药物化学杂志》, 2015.
[71] 展鹏 , 刘新泳 and 刘新泳. Recent applications of click chemistry in drug discovery. Expert Opin Drug Discov, 2019.
[72] 刘新泳 , 展鹏 and 刘新泳. Discovery of novel anti-influenza agents via contemporary medicinal chemistry strategies (2014-2018 update). Future Med Chem, 2019.
[73] 刘新泳 , 刘新泳 , 260101160045 and 展鹏. Molecular design opportunities presented by solvent-exposed regions of target proteins. Med Res Rev., 2019.
[74] 刘新泳 , 展鹏 , 荆兰兰 and 260101160045. Contemporary medicinal-chemistry strategies for the discovery of selective butyrylcholinesterase inhibitors. Drug Discovery Today, 24, 629, 2019.
[75] 展鹏 , 刘新泳 and 康东伟. Discovery of potent HIV-1 non-nucleoside reverse transcriptase inhibitors by exploring the structure-activity relationship of solvent-exposed regions I. Chemical Biology & Drug Design, 93, 430, 2019.
[76] 刘新泳 , 展鹏 and 鞠翰. Inhibitors of Influenza Virus Polymerase Acidic (PA) Endonuclease: Contemporary Developments and Perspectives. Journal of Medicinal Chemistry, 60, 3533, 2017.
[77] 刘新泳 , 展鹏 and 周忠霞. Discovery of novel diarylpyrimidines as potent HIV-1 NNRTIs by investigating the chemical space of a less explored "hydrophobic channel". Organic & Biomolecular Chemistry, 16, 1014, 2018.
[78] 刘新泳 , 展鹏 and 展鹏. Medicinal Chemistry Insights into Novel HDAC Inhibitors: An Updated Patent Review (2012-2016). Recent Patents on Anti-Cancer Drug Discovery, 12, 16, 2017.
[79] 展鹏 , 刘新泳 and 高萍. 1-Hydroxypyrido[2,3-d]pyrimidin-2(1H)-ones as novel selective HIV integrase inhibitors obtained via privileged substructure-based compound libraries. Bioorganic & medicinal chemistry, 25, 5779, 2017.
[80] 黄伯世 , 展鹏 and 刘新泳. Novel diaryltriazines with a picolinonitrile moiety as potent HIV-1 RT inhibitors: a patent evaluation of WO2016059647(A2). Expert Opinion on Therapeutic Patents, 27, 9, 2017.
共 424 条 4/22
首页
上一页
下一页
尾页
页
